Ketamine, Dissociation, and Depression: What Is "Special" About Ketamine? (Revisited).
作者信息
Rizk Mina M, Murrough James W
机构信息
Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
VISN 2 Mental Illness Research, Education, and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, New York, USA.
出版信息
Int J Neuropsychopharmacol. 2024 Jun 1;27(6). doi: 10.1093/ijnp/pyae024.
Abstract
摘要
相似文献
1
Ketamine, Dissociation, and Depression: What Is "Special" About Ketamine? (Revisited).氯胺酮、解离与抑郁：氯胺酮的“特别之处”是什么？（再探讨）
Int J Neuropsychopharmacol. 2024 Jun 1;27(6). doi: 10.1093/ijnp/pyae024.
2
Scopolamine and ketamine: evidence of convergence?东莨菪碱与氯胺酮：是否存在趋同证据？
Biol Psychiatry. 2013 Nov 15;74(10):712-3. doi: 10.1016/j.biopsych.2013.08.011.
3
Ketamine and the potential role for rapid-acting antidepressant medications.氯胺酮及速效抗抑郁药物的潜在作用。
Swiss Med Wkly. 2007 Apr 21;137(15-16):215-6. doi: 10.4414/smw.2007.11932.
4
Blocking NMDA receptor at rest: a possible alleviation of depression.静息时阻断N-甲基-D-天冬氨酸受体：一种缓解抑郁症的可能方法。
Acta Pharmacol Sin. 2011 Sep;32(9):1087-8. doi: 10.1038/aps.2011.113. Epub 2011 Aug 1.
5
Ketamine: A Paradigm Shift for Depression Research and Treatment.氯胺酮：抑郁症研究与治疗的范式转变。
Neuron. 2019 Mar 6;101(5):774-778. doi: 10.1016/j.neuron.2019.02.005.
6
Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?“神秘体验”对于氯胺酮和经典致幻剂的抗抑郁作用是否至关重要？
Eur Arch Psychiatry Clin Neurosci. 2024 Feb 27. doi: 10.1007/s00406-024-01770-7.
7
Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation.氯胺酮诱导解离期间后扣带回皮层的神经节律
Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):583-585. doi: 10.1007/s00406-020-01226-8. Epub 2021 Jan 12.
8
[Ketamine--a new treatment option for therapy-resistant depression].[氯胺酮——难治性抑郁症的一种新治疗选择]
Fortschr Neurol Psychiatr. 2015 Feb;83(2):91-7. doi: 10.1055/s-0034-1398967. Epub 2015 Feb 27.
9
N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.N-甲基-D-天冬氨酸谷氨酸受体拮抗剂与速效抗抑郁药的前景。
Arch Gen Psychiatry. 2010 Nov;67(11):1110-1. doi: 10.1001/archgenpsychiatry.2010.138.
10
Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.拉帕司他尼，一种具有类似氯胺酮抗抑郁作用的新型谷氨酸能药物：趋同机制。
Pharmacol Biochem Behav. 2020 Jan;188:172827. doi: 10.1016/j.pbb.2019.172827. Epub 2019 Nov 13.
本文引用的文献
1
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine.重新审视“解离”作为艾氯胺酮抗抑郁疗效预测指标的作用。
Psychopharmacology (Berl). 2023 Apr;240(4):827-836. doi: 10.1007/s00213-023-06324-8. Epub 2023 Feb 2.
2
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.氯胺酮和血清素能致幻剂：快速抗抑郁治疗作用机制和生物标志物的最新研究进展。
Neuropharmacology. 2023 Mar 15;226:109422. doi: 10.1016/j.neuropharm.2023.109422. Epub 2023 Jan 13.
3
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.氯胺酮辅助心理治疗：文献的系统叙述性综述
J Pain Res. 2022 Jun 15;15:1691-1706. doi: 10.2147/JPR.S360733. eCollection 2022.
4
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.（标题）：难治性抑郁症患者使用氯胺酮鼻喷雾剂的解离与抗抑郁作用之间的关系。
Int J Neuropsychopharmacol. 2022 Apr 19;25(4):269-279. doi: 10.1093/ijnp/pyab084.
5
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.利用裸盖菇素：裸盖菇素在小鼠体内产生的抗抑郁样行为和突触作用不依赖于 5-HT2R 的激活。
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17). doi: 10.1073/pnas.2022489118.
6
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.氯胺酮和血清素能致幻剂：快速作用抗抑郁药作用的共同机制。
Int J Neuropsychopharmacol. 2021 Jan 20;24(1):8-21. doi: 10.1093/ijnp/pyaa087.
7
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.灵活剂量依他佐辛鼻喷雾剂联合新起始口服抗抑郁药治疗难治性抑郁症的疗效和安全性：一项随机、双盲、活性对照研究。
Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21.
8
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.抗抑郁药诱导的脊柱形成持续挽救前额叶回路功能障碍。
Science. 2019 Apr 12;364(6436). doi: 10.1126/science.aat8078.
9
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.单次、重复和维持性氯胺酮输注治疗难治性抑郁症的随机对照试验。
Am J Psychiatry. 2019 May 1;176(5):401-409. doi: 10.1176/appi.ajp.2018.18070834. Epub 2019 Mar 29.
10
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.氯胺酮辅助心理治疗（KAP）：在三家大型机构中，氯胺酮联合心理治疗的患者特征、临床数据和结局。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):189-198. doi: 10.1080/02791072.2019.1587556. Epub 2019 Mar 27.
Zotero 插件